[ad_1] OAK BROOK, Ill., November 30, 2020 / PRNewswire / – Massachusetts General Hospital (MGH) researchers have developed a deep learning model that identifies imaging biomarkers on mammography screening to predict a patient’s risk of developing breast cancer more accurately than traditional assessment tools risk. The results of the study …
Read More »Haoma Medica completes first human trial for NaQuinate, a new treatment under development for osteoporosis
[ad_1] LONDON, November 26, 2020 / PRNewswire / – Haoma Medica today announced the completion of a first human study for NaQuinate, a naphthoquinone carboxylic acid, which is under development as a new orally administered drug for osteoporosis. The first human study launched last year in healthy adults investigated single …
Read More »Discovery of potential treatment against antibiotic-resistant bacteria that cause gonorrhea and meningitis
[ad_1] MONTREAL is LAVAL, November 24, 2020 / CNW Telbec / – A team from National Institute for Scientific Research (INRS) demonstrated the effectiveness of an inexpensive molecule to fight antibiotic-resistant strains of the bacteria responsible for gonorrhea and meningococcal meningitis. These two infections affect millions of people around the …
Read More »Innovent announces Phase I clinical trial results of IBI302, a first-class anti-VEGF and anti-complement ophthalmic recombinant human bi-specific fusion protein for age-related neovascular macular degeneration at 2020 AAO
[ad_1] SAN FRANCISCO and SUZHOU, China, November 15, 2020 / PRNewswire / – Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and markets high-quality medicines for the treatment of oncological, metabolic, autoimmune and other major diseases, announces that the results of Phase Clinical I The …
Read More »SSRI antidepressants may be effective early treatments for COVID-19
[ad_1] Researchers at Washington University School of Medicine in St. Louis published the results of a clinical trial evaluating an antidepressant, fluvoxamine, for early treatment for COVID-19. The study was published in JAMA, The Journal of the American Medical Association, and was funded by the COVID-19 Early Treatment Fund (CETF). …
Read More »Fauna Bio analyzes the broadest set of mammalian genomes to advance biomedical research
[ad_1] EMERYVILLE, California, November 11, 2020 / PRNewswire / – Bio Fauna today announced that the co-founder and Chief Technology Officer, Linda Goodman, is a co-author of a she studies Posted in Nature as part of an international team of researchers with an effort called the Zoonomia Project. The study, …
Read More »Trump Resumes Fraud Allegations / Sources: Could Recognize Defeat Under Certain Conditions – International
[ad_1] US President Donald Trump on Sunday resumed allegations of electoral irregularities, calling for verification of how the minutes were authenticated in the deciding states, but, according to some sources from Washington, he could admit defeat under certain conditions. “We have to control the votes. We have just started the …
Read More »